ZVRA
Zevra Therapeutics, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
11.84
▼ 0.05 (0.41%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
12.03
Prev close
11.89
Day high
12.01
Day low
11.75
Volume
704.11K
Market cap
$704.89M
P/E (TTM)
12.76
52W range
7.16 – 15.04
Day trading desk
Gap from prior close
+1.18%
Prior close 11.89
VWAP
11.88
-0.30% from price
Relative volume
0.36×
Quiet session
Session range
2.38%
11.75 – 12.03
Position in range
33%
Mid range
ATR (14D)
0.49
4.12% of price
Prior day high
12.18
PDH
Prior day low
11.86
PDL
Bid / ask spread
—
Quote not published
Session volume
581.81K
Avg 1.63M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.86%
+6.2%
1M
-5.19%
-8.9%
3M
+13.16%
+10.1%
6M
+34.89%
+23.8%
YTD
+32.48%
+20.2%
1Y
+27.91%
+7.9%
3Y
+128.71%
+54.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Flagged3
Total notional$313.90K
Call notional$226.90K
Put notional$87.00K
Tiltcall-weighted
Likely opening1 of 3
| Side | Strike | Expiry | Volume | Open int. | Vol / OI | Notional | IV | Score | |
|---|---|---|---|---|---|---|---|---|---|
| CALL | 6.00 | Dec 18, 26 116d |
206 | 55 | 3.7× | $126.90K | 83% | mid | 62 |
| CALL | 16.00 | Dec 18, 26 116d |
1.00K | 1.00K | 1.0× | $100.00K | 97% | mid | 41 |
| PUT | 8.00 | Dec 18, 26 116d |
1.45K | 1.45K | 1.0× | $87.00K | 104% | mid | 40 |
How this is calculated, and what it cannot see
A contract is flagged when today's volume approaches or exceeds its open interest, the position is worth at least $40,000, and at least 150 contracts changed hands. Open interest is what was outstanding at yesterday's close, so volume above it means the flow cannot all be closing — something is being opened.
The score weights four things: volume against open interest, dollar notional, volume against the rest of that chain, and where the last print sat inside the bid/ask spread.
What it cannot see. Volume here is a daily total, so ten small orders and one large one are indistinguishable — this is not block or sweep detection, which needs exchange-level time and sales. The print column compares the last trade to the current quote, which is a proxy for who was the aggressor, not a tagged flag. Quotes are delayed. A single large trade can be a hedge, a roll, or one leg of a spread, and none of those mean what a naked directional bet would mean.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ZVRA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+69.22K
Net buying
Buy transactions
4
160.54K shares
Sell transactions
4
91.32K shares
Net transactions
+8
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
747.05K
Total on file
Fundamentals
Market cap$704.89M
Enterprise value$484.81M
Revenue (TTM)$136.07M
Gross profit$129.89M
EBITDA$40.55M
Net income$57.25M
EPS (TTM)$0.93
Free cash flow$48.38M
Total cash$221.57M
Total debt$1.50M
Book value / share$3.48
Shares outstanding59.38M
Float53.90M
Short % of float12.15%
Dividend yield—
Beta (5Y)0.92
Valuation & profitability ratios
Trailing P/E12.76
Forward P/E11.30
PEG ratio10.67
Price / sales—
Price / book3.41
EV / revenue3.56
EV / EBITDA11.96
Gross margin95.46%
Operating margin42.30%
Profit margin42.82%
Return on equity34.80%
Return on assets8.74%
Debt / equity0.69
Current ratio5.17
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $106.47M | $23.61M | $27.46M | $10.16M | +350.9% |
| Operating revenue | $106.47M | $23.61M | $27.46M | $10.16M | +350.9% |
| Cost of revenue | $16.48M | $7.42M | $2.17M | $222.00K | +122.2% |
| Gross profit | $89.99M | $16.20M | $25.29M | $9.94M | +455.7% |
| Research & development | $12.74M | $42.09M | $39.81M | $19.80M | -69.7% |
| Selling, general & admin | $77.62M | $54.87M | $34.31M | $15.04M | +41.5% |
| Total operating expense | $94.22M | $103.20M | $74.89M | $34.84M | -8.7% |
| Operating income | -$4.23M | -$87.00M | -$49.60M | -$24.90M | +95.1% |
| Net interest income | -$1.03M | -$5.18M | $3.04M | $1.18M | +80.1% |
| Pre-tax income | $86.68M | -$90.14M | -$46.05M | -$26.80M | +196.2% |
| Tax provision | $3.45M | $15.37M | $0 | -$33.00K | -77.6% |
| Net income | $83.23M | -$105.51M | -$46.05M | -$26.77M | +178.9% |
| Net income to common | $83.23M | -$105.51M | -$46.05M | -$26.77M | +178.9% |
| Basic EPS | 1.35 | -2.28 | -1.30 | -1.20 | +159.2% |
| Diluted EPS | 1.35 | -2.28 | -1.30 | -1.20 | +159.2% |
| EBIT | $94.66M | -$82.79M | -$44.55M | -$26.47M | +214.3% |
| EBITDA | $98.71M | -$76.40M | -$43.54M | -$25.53M | +229.2% |
| Basic shares | 55.31M | 46.25M | 35.45M | 34.49M | +19.6% |
| Diluted shares | 57.26M | 46.25M | 35.45M | 34.49M | +23.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $62.41M | $33.78M | $43.05M | $65.47M | +84.7% |
| Cash & short-term investments | $191.01M | $69.50M | $67.74M | $82.85M | +174.9% |
| Accounts receivable | $9.88M | $4.01M | $16.12M | $7.18M | +146.3% |
| Inventory | $1.74M | $1.97M | $0 | — | -11.7% |
| Total current assets | $223.01M | $86.03M | $86.94M | $92.83M | +159.2% |
| Property, plant & equipment | $1.70M | $1.01M | $1.53M | $1.78M | +67.9% |
| Goodwill & intangibles | $11.12M | $73.69M | $73.93M | $0 | -84.9% |
| Total assets | $284.73M | $178.13M | $172.33M | $115.34M | +59.8% |
| Total current liabilities | $39.28M | $34.06M | $73.72M | $12.02M | +15.3% |
| Current debt | — | — | $37.70M | $4.66M | — |
| Long-term debt | $61.93M | $59.50M | $5.07M | $12.80M | +4.1% |
| Total debt | $63.21M | $60.30M | $43.77M | $14.12M | +4.8% |
| Total liabilities | $130.07M | $138.46M | $110.46M | $40.22M | -6.1% |
| Retained earnings | -$422.06M | -$505.29M | -$399.78M | -$353.73M | +16.5% |
| Shareholder equity | $154.66M | $39.67M | $61.86M | $75.12M | +289.9% |
| Working capital | $183.73M | $51.96M | $13.22M | $80.81M | +253.6% |
| Net tangible assets | $143.53M | -$34.03M | -$12.06M | $75.12M | +521.8% |
| Shares issued | 58.34M | 55.25M | 43.11M | 35.45M | +5.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $83.23M | -$105.51M | -$46.05M | -$26.77M | — | +178.9% |
| Depreciation & amortisation | $4.05M | $6.39M | $1.01M | $944.00K | — | -36.5% |
| Stock-based compensation | $12.63M | $14.91M | $5.95M | $4.29M | — | -15.2% |
| Change in working capital | -$26.51M | -$7.19M | $5.88M | -$406.00K | — | -268.6% |
| Operating cash flow | -$1.60M | -$69.67M | -$33.53M | -$18.72M | — | +97.7% |
| Capital expenditure | -$835.00K | — | -$296.00K | -$93.00K | -$102.00K | — |
| Investing cash flow | $18.13M | -$22.16M | -$17.39M | -$36.72M | — | +181.8% |
| Share buybacks | — | $0 | -$3.45M | -$4.72M | -$2.81M | — |
| Financing cash flow | $12.06M | $82.11M | $28.46M | $8.35M | — | -85.3% |
| Free cash flow | -$2.43M | -$69.67M | -$33.83M | -$18.81M | — | +96.5% |
| End cash position | $62.41M | $33.78M | $43.05M | $65.47M | — | +84.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $39.66M | $36.22M | $34.13M | $26.06M | $25.88M | — | +9.5% |
| Operating revenue | $39.66M | $36.22M | $34.13M | $26.06M | $25.88M | — | +9.5% |
| Cost of revenue | $1.52M | $1.90M | $1.52M | $1.24M | $12.38M | — | -19.6% |
| Gross profit | $38.14M | $34.32M | $32.60M | $24.82M | $13.50M | — | +11.1% |
| Research & development | $4.49M | $4.39M | $2.62M | $3.43M | $3.43M | — | +2.1% |
| Selling, general & admin | $16.56M | $20.78M | $20.35M | $16.93M | $20.78M | — | -20.3% |
| Total operating expense | $21.36M | $25.49M | $23.29M | $20.68M | $25.83M | — | -16.2% |
| Operating income | $16.78M | $8.83M | $9.31M | $4.14M | -$12.33M | — | +90.0% |
| Net interest income | $2.56M | $1.88M | -$236.00K | $262.00K | $369.00K | — | +36.6% |
| Pre-tax income | $12.79M | $44.80M | $12.67M | -$977.00K | $76.91M | — | -71.4% |
| Tax provision | $4.04M | $6.91M | $501.00K | -$433.00K | $2.20M | — | -41.5% |
| Net income | $8.75M | $37.89M | $12.16M | -$544.00K | $74.71M | — | -76.9% |
| Net income to common | $8.75M | $37.89M | $12.16M | -$544.00K | $74.71M | — | -76.9% |
| Basic EPS | 0.14 | 0.62 | — | -0.01 | 1.24 | -0.06 | -77.4% |
| Diluted EPS | 0.14 | 0.60 | — | -0.01 | 1.21 | -0.06 | -76.7% |
| EBIT | $12.79M | $46.52M | $14.61M | $1.07M | $78.92M | — | -72.5% |
| EBITDA | $13.16M | $46.88M | $14.98M | $1.47M | $80.57M | — | -71.9% |
| Basic shares | 59.16M | 58.41M | — | 55.95M | 54.78M | 54.10M | +1.3% |
| Diluted shares | 61.34M | 60.23M | — | 55.95M | 56.32M | 54.10M | +1.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $145.32M | $95.59M | $62.41M | $54.44M | $47.71M | — | +52.0% |
| Cash & short-term investments | $221.57M | $200.62M | $191.01M | $199.51M | $202.61M | — | +10.4% |
| Accounts receivable | $10.33M | $7.65M | $9.88M | $8.77M | $9.80M | — | +35.0% |
| Inventory | $2.45M | $2.31M | $1.74M | $1.37M | $1.11M | — | +6.0% |
| Total current assets | $251.30M | $229.97M | $223.01M | $225.12M | $226.34M | — | +9.3% |
| Property, plant & equipment | $2.31M | $1.52M | $1.70M | $1.82M | $2.10M | — | +52.1% |
| Goodwill & intangibles | $10.49M | $10.81M | $11.12M | $11.44M | $11.75M | — | -2.9% |
| Total assets | $302.71M | $278.58M | $284.73M | $270.12M | $256.28M | — | +8.7% |
| Total current liabilities | $48.63M | $47.03M | $39.28M | $26.11M | $28.83M | — | +3.4% |
| Long-term debt | — | — | $61.93M | $61.31M | $60.69M | $60.09M | — |
| Total debt | $1.50M | $1.15M | $63.21M | $62.72M | $62.28M | — | +30.4% |
| Total liabilities | $85.06M | $72.78M | $130.07M | $136.95M | $139.05M | — | +16.9% |
| Retained earnings | -$375.42M | -$384.17M | -$422.06M | -$434.23M | -$433.68M | — | +2.3% |
| Shareholder equity | $217.65M | $205.80M | $154.66M | $133.16M | $117.23M | — | +5.8% |
| Working capital | $202.67M | $182.94M | $183.73M | $199.00M | $197.50M | — | +10.8% |
| Net tangible assets | $207.16M | $195.00M | $143.53M | $121.73M | $105.48M | — | +6.2% |
| Shares issued | 59.34M | 60.69M | 58.34M | 57.79M | 56.66M | — | -2.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $8.75M | $37.89M | $12.16M | -$544.00K | $74.71M | — | -76.9% |
| Depreciation & amortisation | $364.00K | $368.00K | $362.00K | $392.00K | $1.65M | — | -1.1% |
| Stock-based compensation | $2.97M | $3.10M | $4.28M | $2.77M | $2.46M | — | -4.4% |
| Change in working capital | -$926.00K | $9.59M | -$10.05M | -$2.33M | -$7.29M | — | -109.7% |
| Operating cash flow | $17.03M | $6.14M | $5.52M | $4.71M | -$3.60M | — | +177.3% |
| Capital expenditure | -$217.00K | -$35.00K | — | -$554.00K | -$213.00K | -$99.00K | -520.0% |
| Investing cash flow | $31.45M | $79.62M | $227.00K | -$4.58M | $11.93M | — | -60.5% |
| Share buybacks | — | — | — | — | — | — | — |
| Financing cash flow | $1.58M | -$52.80M | $2.55M | $6.53M | $1.38M | — | +103.0% |
| Free cash flow | $16.82M | $6.11M | $5.55M | $4.16M | -$3.81M | — | +175.3% |
| End cash position | $145.32M | $95.59M | $62.41M | $54.44M | $47.71M | — | +52.0% |
Options analytics
Put / call volume
2.08
Put-heavy session
Put / call open interest
0.26
Positioning, not flow
Max pain
9.00
-24.2% from spot
ATM implied vol
62.9%
Nearest strike to spot
Skew (10% OTM)
+18.4%
Puts bid over calls
Call volume
60
Contracts, this expiry
Put volume
125
Contracts, this expiry
Heaviest call OI
12.00
124 contracts
Heaviest put OI
12.00
88 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.16 | 0.25 | +56.3% |
| Mar 2026 | 0.08 | 0.18 | +114.9% |
| Dec 2025 | 0.05 | 0.19 | +322.2% |
| Sep 2025 | -0.02 | -0.01 | +50.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.18 | 4 | $37.08M | +42.3% |
| Next quarter | 0.20 | 4 | $39.57M | +15.9% |
| Current year | 1.14 | 4 | $152.22M | +43.0% |
| Next year | 1.05 | 4 | $176.98M | +16.3% |
Analyst targets & ownership
Mean target$25.00
High target$35.00
Low target$20.00
Implied upside111.13%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy2 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders1.26%
Held by institutions77.15%
Institutions holding217
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.57
+2.30% from price
SMA 20
10.93
+8.57% from price
SMA 50
12.21
-2.78% from price
SMA 100
11.39
+3.98% from price
SMA 200
10.15
+16.91% from price
EMA 12
11.54
+2.60% from price
EMA 26
11.54
+2.58% from price
EMA 50
11.63
+1.84% from price
RSI (14)
54.0
Neutral
MACD (12,26,9)
-0.00
Hist 0.18
ATR (14)
0.49
4.11% of price
Realised vol 30D
94.5%
Annualised
Bollinger upper
12.68
20, 2σ
Bollinger lower
9.18
20, 2σ
50 / 200 cross
Golden
12.21 vs 10.15
Trend bias
Above 200
+16.91%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.77
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
94.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-35.5%
Peak to trough
Max drawdown 5Y
-60.8%
Peak to trough
ATR 14
0.49
4.11% of price
Beta (reported)
0.92
5Y monthly, from filing
Short interest
Shares short
7.13M
Prior 6.49M
Change vs prior
+9.9%
Shorts adding
% of float
12.15%
Elevated
% of shares out
12.01%
Against total outstanding
Days to cover
4.6
Liquid
Float
53.90M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 27, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 27, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 23, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 11, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jun 10, 26 | Maxim Group | MAINTAINED | Buy | Buy |
| Jun 10, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jun 9, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 9, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateDec 28, 2020
Last split1:16
Split dateDec 28, 2020
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-05
Periodic Financial Reports
10-Q · 2026-05-06
Proxy Statements
DEF 14A · 2026-04-20
Proxy Statements
PRE 14A · 2026-04-06
Corporate Changes & Voting Matters
8-K · 2026-03-16
Offering Registrations
S-8 · 2026-03-09
Corporate Changes & Voting Matters
8-K · 2025-12-17
Headlines
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 2d ago
Zevra Therapeutics Insider Sold Shares Worth $474,774, According to a Recent SEC Filing
MT Newswires · 6d ago
What Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review?
Simply Wall St. · 17d ago
Zevra Therapeutics Q2 Earnings Call Highlights
MarketBeat · 17d ago
Zevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights: Revenue Surges 53% as ...
GuruFocus.com · 18d ago
Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates
Zacks · 18d ago
Zevra Therapeutics: Q2 Earnings Snapshot
Associated Press · 18d ago
Zevra Reports Second Quarter 2026 Financial Results and Corporate Update
GlobeNewswire · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.